Google has added new guidance to the "Fix Search-related JavaScript problems" help document, specifically addressing JavaScript-based paywalls.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a clinical-stage biotechnology company integrating artificial intelligence ...

SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...

Clinical-stage biotech Recursion Pharmaceuticals ' (NASDAQ: RXRX) stock took it on the chin in the first trading day of the week. Monday saw investors back out of the company's shares, leaving ...

Mixture-of-Recursions (MoR) is a new AI architecture that promises to cut LLM inference costs and memory use without sacrificing performance.

Recursion Pharmaceuticals is a clinical-stage TechBio company that leverages artificial intelligence (AI), automation, and experimental biology to accelerate the discovery and development of new ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting everything on AI to beat the odds.

The latest JavaScript specification standardizes a well-balanced and thoughtful set of features, including the built-in global Iterator, new Set methods, improvements to regular expressions, and more.